Class information for:
Level 1: ALDOSTERONE//EPLERENONE//SPIRONOLACTONE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2008 2324 42.9 86%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1985 5079 11 BETA HYDROXYSTEROID DEHYDROGENASE//ALDOSTERONE//EPLERENONE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ALDOSTERONE Author keyword 241 24% 38% 874
2 EPLERENONE Author keyword 181 67% 7% 163
3 SPIRONOLACTONE Author keyword 114 35% 11% 267
4 MINERALOCORTICOID RECEPTOR Author keyword 91 31% 10% 244
5 ALDOSTERONE BREAKTHROUGH Author keyword 31 92% 1% 12
6 MINERALOCORTICOID RECEPTOR ANTAGONIST Author keyword 24 63% 1% 24
7 MINERALOCORTICOID RECEPTOR ANTAGONISTS Author keyword 22 57% 1% 26
8 MINERALOCORTICOIDS Author keyword 13 25% 2% 46
9 SELECTIVE ALDOSTERONE BLOCKER Author keyword 12 86% 0% 6
10 ALDOSTERONE ESCAPE Author keyword 11 60% 1% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ALDOSTERONE 241 24% 38% 874 Search ALDOSTERONE Search ALDOSTERONE
2 EPLERENONE 181 67% 7% 163 Search EPLERENONE Search EPLERENONE
3 SPIRONOLACTONE 114 35% 11% 267 Search SPIRONOLACTONE Search SPIRONOLACTONE
4 MINERALOCORTICOID RECEPTOR 91 31% 10% 244 Search MINERALOCORTICOID+RECEPTOR Search MINERALOCORTICOID+RECEPTOR
5 ALDOSTERONE BREAKTHROUGH 31 92% 1% 12 Search ALDOSTERONE+BREAKTHROUGH Search ALDOSTERONE+BREAKTHROUGH
6 MINERALOCORTICOID RECEPTOR ANTAGONIST 24 63% 1% 24 Search MINERALOCORTICOID+RECEPTOR+ANTAGONIST Search MINERALOCORTICOID+RECEPTOR+ANTAGONIST
7 MINERALOCORTICOID RECEPTOR ANTAGONISTS 22 57% 1% 26 Search MINERALOCORTICOID+RECEPTOR+ANTAGONISTS Search MINERALOCORTICOID+RECEPTOR+ANTAGONISTS
8 MINERALOCORTICOIDS 13 25% 2% 46 Search MINERALOCORTICOIDS Search MINERALOCORTICOIDS
9 SELECTIVE ALDOSTERONE BLOCKER 12 86% 0% 6 Search SELECTIVE+ALDOSTERONE+BLOCKER Search SELECTIVE+ALDOSTERONE+BLOCKER
10 ALDOSTERONE ESCAPE 11 60% 1% 12 Search ALDOSTERONE+ESCAPE Search ALDOSTERONE+ESCAPE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EPLERENONE 230 63% 10% 233
2 SPIRONOLACTONE 212 37% 20% 464
3 MINERALOCORTICOID RECEPTOR 74 24% 12% 275
4 PRONE HYPERTENSIVE RATS 67 73% 2% 51
5 SELECTIVE ALDOSTERONE BLOCKER 62 62% 3% 63
6 RANDOMIZED ALDACTONE EVALUATION 62 67% 2% 56
7 ALDOSTERONE 46 12% 16% 370
8 CARDIAC FIBROSIS 43 28% 6% 133
9 BENEFICIAL IMPACT 35 86% 1% 18
10 ALDOSTERONE BLOCKADE 32 57% 2% 38

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Role of Mineralocorticoid Receptor Antagonists in Cardiovascular Disease 2015 4 84 69%
Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases 2015 2 103 83%
Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals 2015 2 85 72%
Aldosterone: effects on the kidney and cardiovascular system 2010 98 137 78%
Vascular Actions of Aldosterone 2013 23 83 88%
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension 2009 150 45 64%
Aldosterone synthase inhibitors in cardiovascular and renal diseases 2014 9 38 82%
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis 2013 22 126 74%
The incidence and implications of aldosterone breakthrough 2007 131 37 78%
Aldosterone and vascular inflammation 2008 121 93 72%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 U478 6 21% 1.1% 26
2 JULIUS BERNSTEIN PHYSIOL 4 18% 0.9% 21
3 STICA 3 100% 0.1% 3
4 FEDERATIF RECH CELLULES EPITHELIALES 3 45% 0.2% 5
5 WELLCOME TRUST CELLULAR PHYSIOL UNIT 3 33% 0.3% 7
6 INVEST CLIN 9501 3 24% 0.4% 10
7 UNIT 961 2 67% 0.1% 2
8 ENDOCRINOL DIABET HYPERTENS MED 2 26% 0.3% 7
9 CTO A ALESINI HOSP 2 50% 0.1% 3
10 U9501 2 50% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000147902 PSEUDOHYPOALDOSTERONISM//TRANSIENT PSEUDOHYPOALDOSTERONISM//PSEUDOHYPOALDOSTERONISM TYPE I
2 0.0000126477 PRIMARY ALDOSTERONISM//ALDOSTERONE PRODUCING ADENOMA//ADRENAL VEIN SAMPLING
3 0.0000117393 INTRACELLULAR CALCIUM OVERLOADING//CARDIOMYOCYTE NECROSIS//ALDOSTERONISM
4 0.0000082717 INSERM E9912//ZK 91587//LIALH4 REDUCTION
5 0.0000072298 11 BETA HYDROXYSTEROID DEHYDROGENASE//11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1//11 BETA HSD1
6 0.0000071258 HIGH BLOOD P SURE UNIT//ADRENOCORTICOTROPHIC HORMONE//GLUCOCORTICOID INDUCED HYPERTENSION
7 0.0000069138 SGK1//SERUM AND GLUCOCORTICOID INDUCIBLE KINASE//SERUM AND GLUCOCORTICOID INDUCIBLE KINASE
8 0.0000065462 HYPERKALEMIA//KAYEXALATE//HYPERKALAEMIA
9 0.0000064433 NONMODULATION//HYPERTENSION NONMODULATING//EXTREME NORTH
10 0.0000062629 SAN ANTONIO CARDIOVASC PROTE//CARDIAC FIBROBLASTS//MISSISSIPPI HEART